Performance of the Enhanced Liver Fibrosis Test to Estimate Advanced Fibrosis Among Patients With Nonalcoholic Fatty Liver Disease

IMPORTANCE: The most important surrogate for increased risk of adverse clinical outcomes among patients with nonalcoholic fatty liver disease (NAFLD) is the patient’s stage of liver fibrosis. There is a significant barrier to risk-stratifying patients in clinical practice owing to the need for liver...

Descripción completa

Detalles Bibliográficos
Autores principales: Younossi, Zobair M., Felix, Sean, Jeffers, Thomas, Younossi, Elena, Nader, Fatema, Pham, Huong, Afendy, Arian, Cable, Rebecca, Racila, Andrei, Younoszai, Zahra, Lam, Brian P., Golabi, Pegah, Henry, Linda, Stepanova, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446814/
https://www.ncbi.nlm.nih.gov/pubmed/34529067
http://dx.doi.org/10.1001/jamanetworkopen.2021.23923

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446814/
https://www.ncbi.nlm.nih.gov/pubmed/34529067
http://dx.doi.org/10.1001/jamanetworkopen.2021.23923

Ejemplares similares